Theragenics Signs Agreement with GE Healthcare Unit

Theragenics Corporation TGX today announced it has signed a value-added loading services agreement with Oncura, a unit of GE Healthcare GE, to provide worldwide brachytherapy loading services to Oncura. Under the three-year agreement, Theragenics will load and package Oncura manufactured brachytherapy seeds in prescription loaded needles, custom strands and other configurations. Oncura's iodine-125 brachytherapy seeds are utilized primarily in the treatment of early stage prostate cancer. This agreement provides for loading services for most Oncura sales of prescription and custom loaded brachytherapy seeds worldwide, which currently includes North America, Europe, Australia and portions of Asia. Theragenics See full press release